CBRE Group, Inc.
CBRE Group, Inc. (CBRE) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for CBRE Group, Inc. (CBRE), featuring income statements, balance sheets, and cash flow data.
CBRE Group, Inc. (CBRE) Income Statement & Financial Overview
Analyze CBRE Group, Inc.’s CBRE earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $8.91B | $10.40B | $9.04B | $8.39B |
| Cost of Revenue | $7.26B | $7.97B | $7.25B | $6.95B |
| Gross Profit | $1.65B | $2.43B | $1.78B | $1.44B |
| Gross Profit Ratio | $0.18 | $0.23 | $0.20 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.19B | $1.47B | $1.24B | $1.19B |
| Operating Expenses | $1.37B | $1.52B | $1.42B | $1.35B |
| Total Costs & Expenses | $8.63B | $9.81B | $8.67B | $8.14B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $50.00M | $52.00M | $64.00M | $63.00M |
| Depreciation & Amortization | $177.00M | $177.00M | $178.00M | $161.00M |
| EBITDA | $453.00M | $641.00M | $547.00M | $407.00M |
| EBITDA Ratio | $0.05 | $0.06 | $0.06 | $0.05 |
| Operating Income | $276.00M | $594.00M | $368.00M | $246.00M |
| Operating Income Ratio | $0.03 | $0.06 | $0.04 | $0.03 |
| Other Income/Expenses (Net) | -$33.00M | $19.00M | -$56.00M | -$72.00M |
| Income Before Tax | $243.00M | $613.00M | $312.00M | $174.00M |
| Income Before Tax Ratio | $0.03 | $0.06 | $0.03 | $0.02 |
| Income Tax Expense | $52.00M | $112.00M | $67.00M | $32.00M |
| Net Income | $163.00M | $487.00M | $225.00M | $130.00M |
| Net Income Ratio | $0.02 | $0.05 | $0.02 | $0.02 |
| EPS | $0.54 | $1.59 | $0.73 | $0.42 |
| Diluted EPS | $0.54 | $1.58 | $0.73 | $0.42 |
| Weighted Avg Shares Outstanding | $305.86M | $306.25M | $306.25M | $306.75M |
| Weighted Avg Shares Outstanding (Diluted) | $308.03M | $308.31M | $308.31M | $308.04M |
Over the past four quarters, CBRE Group, Inc. demonstrated steady revenue growth, increasing from $8.39B in Q2 2024 to $8.91B in Q1 2025. Operating income reached $276.00M in Q1 2025, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $453.00M, reflecting operational efficiency. Net income dropped to $163.00M, with EPS at $0.54. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan